GW843682X New
* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS No. | 660868-91-7 | Cat. No. | BCP27639 |
Name | GW843682X | ||
Synonyms | GW 843682X; GW-843682X; | ||
SMILES | COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC | ||
Chemical Name | |||
Formula | C22H18F3N3O4S | M. Wt | 477.46 |
Purity | 98% | Storage | Store at 4-8°C |
Description | GW843682X is a selective inhibitor of polo-like kinase 1 (PLK1) and polo-like kinase 3 (PLK3) (IC50 values are 2.2 and 9.1 nM respectively). GW843682X inhibited the proliferation and induced apoptosis of 5-8F cells in a dose-dependent manner (IC50=62.5-125nmol/L). GW843682X exhibited remarkable cytotoxic effects on nasopharyngeal carcinoma 5-8F cells by down-regulating IAP gene expression, suggesting that GW843682X may become a novel therapeutic agent for nasopharyngeal carcinoma. |
Recommend Products
More >-
Onvansertib fumarate
Cat. No.:BCP49273
No.:1263293-37-3
Product Details -
TC-S 7005
Cat. No.:BCP48202
No.:1082739-92-1
Product Details -
-
ON1231320
Cat. No.:BCP40722
No.:1312471-39-8
Product Details -
-
CFI-400437
Cat. No.:BCP29569
No.:1247000-76-5
Product Details -
TAK-960 hydrochloride
Cat. No.:BCP28992
No.:1137868-96-2
Product Details -
CFI-400945 fumarate
Cat. No.:BCP25931
No.:1616420-30-4
Product Details -
-
Mps1-in-2
Cat. No.:BCP19164
No.:1228817-38-6
Product Details -
Centrinone
Cat. No.:BCP17384
No.:1798871-30-3
Product Details -
-
SBE 13 hydrochloride
Cat. No.:BCP23836
No.:1052532-15-6
Product Details -
LFM-A13(Z)
Cat. No.:BCP12817
No.:244240-24-2
Product Details -
Onvansertib
Cat. No.:BCP28066
No.:1034616-18-6
Product Details -
-
-
-
-
Rigosertib
Cat. No.:BCP08296
No.:592542-59-1
Product Details
Tags:GW843682X supplier,GW843682X purchase,GW843682X manufacturer,GW843682X distributor,GW843682X cost,GW843682X buy,GW843682X for sale